HHS has released a list of 43 prescription drugs for which Part B beneficiary coinsurances may be lower starting July 1.“The Medicare Prescription Drug Inflation Rebate Program is a critical way to address long-term price increases by drug companies, and CMS is continuing our work to make prescription drugs more affordable for people with Medicare,” CMS Administrator Chiquita Brooks-LaSure said in a press release. “CMS is working tirelessly to ensure timely implementation of the Inflation Reduction Act to strengthen Medicare now and in the future.”Because of theRead More
- (305) 687-1367
- info@flgastro.org
- Mon - Fri: 9:00am - 5:00pm